SRPT logo

SRPT
Sarepta Therapeutics Inc

26,645
Mkt Cap
$2.43B
Volume
2.04M
52W High
$127.91
52W Low
$10.42
PE Ratio
-8.24
SRPT Fundamentals
Price
$23.83
Prev Close
$23.15
Open
$23.67
50D MA
$20.64
Beta
1.10
Avg. Volume
2.95M
EPS (Annual)
$2.34
P/B
1.89
Rev/Employee
$1.39M
Loading...
Loading...
News
all
press releases
Sarepta Therapeutics Announces Submission of Clinical Trial Application for SRP-1005, its Investigational Treatment for Huntingtons Disease
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced the submission of its clinical trial application (CTA) for Study SRP-1005-101...
Business Wire·3d ago
News Placeholder
More News
News Placeholder
Sarepta Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will present at the 44th Annual J.P. Morgan Healthcare...
Business Wire·5d ago
News Placeholder
Sarepta Therapeutics, Inc. $SRPT Shares Acquired by Cwm LLC
Cwm LLC lifted its holdings in Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) by 4,033.3% in the third quarter, according to its most recent filing with the Securities and Exchange Commission...
MarketBeat·6d ago
News Placeholder
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, granted equity awards on Dec. 31, 2025 that were previously approved by the Compensation...
Business Wire·10d ago
News Placeholder
Voya Investment Management LLC Trims Stock Holdings in Sarepta Therapeutics, Inc. $SRPT
Voya Investment Management LLC trimmed its stake in Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) by 99.5% during the third quarter, according to its most recent 13F filing with the SEC. The...
MarketBeat·11d ago
News Placeholder
Assenagon Asset Management S.A. Sells 838,457 Shares of Sarepta Therapeutics, Inc. $SRPT
Assenagon Asset Management S.A. reduced its position in shares of Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Free Report) by 96.6% in the third quarter, according to the company in its most recent...
MarketBeat·16d ago
News Placeholder
Sarepta Therapeutics (NASDAQ:SRPT) Stock Price Up 3.5% - Here's What Happened
Sarepta Therapeutics (NASDAQ:SRPT) Shares Up 3.5% - Time to Buy...
MarketBeat·18d ago
News Placeholder
What Does the Market Think About Sarepta Therapeutics Inc?
read more...
Benzinga·22d ago
News Placeholder
Ian Michael Estepan Sells 13,187 Shares of Sarepta Therapeutics (NASDAQ:SRPT) Stock
Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Get Free Report) COO Ian Michael Estepan sold 13,187 shares of the firm's stock in a transaction on Tuesday, December 16th. The shares were sold at an...
MarketBeat·22d ago
News Placeholder
Sarepta Therapeutics (NASDAQ:SRPT) COO Ian Michael Estepan Sells 13,187 Shares
Sarepta Therapeutics, Inc. (NASDAQ:SRPT - Get Free Report) COO Ian Michael Estepan sold 13,187 shares of the company's stock in a transaction on Tuesday, December 16th. The shares were sold at an...
MarketBeat·23d ago
<
1
2
...
>

Latest SRPT News

View

Advertisement|Remove ads.

Advertisement|Remove ads.